Neutrophil Activation and Resistance to Recombinant Human Erythropoietin Therapy in Hemodialysis Patients | Zendy

Elı́sio Costa | Zendy; Susana Rocha | Zendy; Petronila RochaPereira | Zendy; Henrique Nascimento | Zendy; Elisabeth Castro | Zendy; Vasco Miranda | Zendy; Maria Faria | Zendy; Alfredo Loureiro | Zendy; Alexandre Quintanilha | Zendy; Luı́s Belo | Zendy; Alice SantosSilva | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Neutrophil Activation and Resistance to Recombinant Human Erythropoietin Therapy in Hemodialysis Patients

Author(s) -

Elı́sio Costa,

Susana Rocha,

Petronila RochaPereira,

Henrique Nascimento,

Elisabeth Castro,

Vasco Miranda,

Maria Faria,

Alfredo Loureiro,

Alexandre Quintanilha,

Luı́s Belo,

Alice SantosSilva

Publication year - 2008

Publication title -

american journal of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.394

H-Index - 85

eISSN - 1421-9670

pISSN - 0250-8095

DOI - 10.1159/000142147

Subject(s) - medicine , hemodialysis , erythropoietin , elastase , lactoferrin , dialysis , kidney disease , gastroenterology , hemoglobin , neutrophil elastase , immunology , inflammation , biochemistry , chemistry , biology , genetics , enzyme

The aim of this work was to evaluate the neutrophil activation state in chronic kidney disease (CKD) patients under hemodialysis, and its linkage with resistance to recombinant human erythropoietin (rhEPO) therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research